Allianthera (suzhou) Biopharmaceuticals Co., Ltd.

This was the first-ever study in humans of an experimental oral drug called YUQ-A1007. It was tested in 47 healthy volunteers to check its basic safety, how well it's tolerated, and how the body processes it. The drug is designed to act in the gut and early lab research suggests …